Alyeska Investment Group’s Vaxcyte PCVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$25.3M Buy
435,581
+190,806
+78% +$10.4M 0.07% 289
2025
Q4
$11.3M Hold
244,775
0.03% 371
2025
Q3
$8.82M Hold
244,775
0.03% 394
2025
Q2
$7.96M Buy
244,775
+80,135
+49% +$2.63M 0.03% 378
2025
Q1
$6.22M Sell
164,640
-32,945
-17% -$2.63M 0.02% 349
2024
Q4
$16.2M Sell
197,585
-21,246
-10% -$2.11M 0.06% 282
2024
Q3
$25M Buy
+218,831
New +$19.7M 0.13% 215
2024
Q1
Sell
-25,000
Closed -$1.57M 618
2023
Q4
$1.57M Hold
25,000
0.01% 388
2023
Q3
$1.27M Hold
25,000
0.01% 411
2023
Q2
$1.25M Sell
25,000
-20,000
-44% -$948K 0.01% 441
2023
Q1
$1.69M Hold
45,000
0.01% 367
2022
Q4
$2.16M Sell
45,000
-7,100
-14% -$279K 0.02% 310
2022
Q3
$1.25M Hold
52,100
0.01% 340
2022
Q2
$1.13M Hold
52,100
0.01% 455
2022
Q1
$1.26M Buy
+52,100
New +$1.14M 0.01% 479

Other funds holding PCVX